个人中心 - 老虎社区

ALi_BaBa

IP属地：未知

帖子 · 222帖子 · 222
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ALi_BaBaALi_BaBa
  ·2021-12-17
  Sad
  非常抱歉，此主贴已删除
  1,177 1
  3
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-16
  Great
  Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'
  Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s "Person of t
  Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'
  1,068 评论
  5
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-15
  Great
  Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival
  Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t
  Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival
  1,128 评论
  4
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-13
  Like
  非常抱歉，此主贴已删除
  1,036 评论
  点赞
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-13
  Hi
  非常抱歉，此主贴已删除
  1,264 评论
  2
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-09
  Like
  非常抱歉，此主贴已删除
  1,424 2
  1
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-07
  Lol
  非常抱歉，此主贴已删除
  1,196 评论
  1
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-03
  Sad
  非常抱歉，此主贴已删除
  1,218 1
  6
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-02
  Great
  2 Ridiculously Cheap Dividend Stocks To Buy for 2022
  The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could
  2 Ridiculously Cheap Dividend Stocks To Buy for 2022
  804 1
  3
  分享
  举报
- ALi_BaBaALi_BaBa
  ·2021-12-01
  Sad
  Regeneron's COVID-19 antibody drug may be less effective against Omicron
  Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag
  Regeneron's COVID-19 antibody drug may be less effective against Omicron
  863 评论
  4
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3564105303063302","uuid":"3564105303063302","gmtCreate":1601011280020,"gmtModify":1611395862509,"name":"ALi_BaBa","pinyin":"alibabaalibaba","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":18,"headSize":552,"tweetSize":222,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.25","exceedPercentage":"93.42%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":690769005,"gmtCreate":1639709658624,"gmtModify":1639709721510,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690769005","repostId":"2192920942","repostType":4,"isVote":1,"tweetType":1,"viewCount":1177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690005827,"gmtCreate":1639611295764,"gmtModify":1639611295966,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690005827","repostId":"1117099747","repostType":4,"repost":{"id":"1117099747","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639610664,"share":"https://www.laohun8.com/m/news/1117099747?lang=&edition=full","pubTime":"2021-12-16 07:24","market":"us","language":"en","title":"Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'","url":"https://stock-news.laohu8.com/highlight/detail?id=1117099747","media":"Benzinga","summary":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of t","content":"<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBad Omen For Tesla? Here's What Happened To Amazon Stock After Jeff Bezos Was Time's 'Person Of The Year'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-16 07:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Controversial and influential&nbsp;<b>Tesla Inc</b>&nbsp;<b>CEO Elon Musk</b>was recently named&nbsp;<b>Time Magazine’s \"Person of the Year\" for 2021</b>. The award is a tremendous honor for Musk, but some long-time&nbsp;<b>Amazon.com, Inc.</b>&nbsp;investors may still have nightmares about the time Amazon founder and former CEO&nbsp;<b>Jeff Bezos</b>&nbsp;was also named Time’s \"Person of the Year.\"</p>\n<p><b>Time Magazine Curse?</b>Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.<b>During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.</b></p>\n<p>Bezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.</p>\n<p>Tesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.</p>\n<p><b>Tesla Risk:</b>Former hedge fund manager Whitney Tilson said Wednesday&nbsp;he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.</p>\n<p>“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.</p>\n<p><b>Benzinga’s Take:</b>The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of&nbsp;other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,<b>Microsoft Corporation</b>&nbsp;stock was up 31.3%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117099747","content_text":"Controversial and influential Tesla Inc CEO Elon Muskwas recently named Time Magazine’s \"Person of the Year\" for 2021. The award is a tremendous honor for Musk, but some long-time Amazon.com, Inc. investors may still have nightmares about the time Amazon founder and former CEO Jeff Bezos was also named Time’s \"Person of the Year.\"\nTime Magazine Curse?Bezos received \"Person of the Year\" honors for 1999 on Dec. 20, 1999. On that day, Amazon shares closed at $97. Less than two years later, Amazon shares closed at a new all-time low of $5.67 on Sept. 27, 2001.During that 11-month stretch immediately following Bezos’ award, Amazon shares lost an incredible 94% of their value.\nBezos and Musk have had a somewhat contentious rivalry over the years. Musk and Bezos are also currently the two most wealthy people in the world, worth a combined $437 billion.\nTesla investors are hoping Tesla shares can avoid the same Time Magazine curse that hit Amazon stock back in 1999. So far, they have not. Musk was announced as \"Person of the Year\" on Monday, and Tesla shares are now down 7.6% since last Friday’s close.\nTesla Risk:Former hedge fund manager Whitney Tilson said Wednesday he does not expect Tesla to repeat Amazon’s 94% Time Magazine sell-off, and he would not recommend traders short Tesla stock.\n“But I will say this: as I scan the 100 companies with the largest market caps that trade in the U.S., Tesla jumps out at me as the one that could cost investors the most money, the fastest…” Tilson said.\nBenzinga’s Take:The silver lining for Amazon investors that held on through the bursting of the dot-com bubble is Amazon’s stock has been a more than 600-bagger since it bottomed in 2001. In addition, the stocks of other billionaire tech CEOs have fared much better following \"Person of the Year\" honors. In the two years after Bill Gates was named Time \"Person of the Year\" in 2005,Microsoft Corporation stock was up 31.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607249932,"gmtCreate":1639551927828,"gmtModify":1639551928057,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607249932","repostId":"1160618167","repostType":4,"repost":{"id":"1160618167","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639551825,"share":"https://www.laohu8.com/m/news/1160618167?lang=&edition=full","pubTime":"2021-12-15 15:03","market":"us","language":"en","title":"Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival","url":"https://stock-news.laohu8.com/highlight/detail?id=1160618167","media":"Benzinga","summary":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t","content":"<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-15 15:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","ARKQ":"ARK Autonomous Technology & Robotics ETF","JD":"京东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160618167","content_text":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV) on the dip.\nArk Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.\nXpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.\nXpeng and other Chinese peer shares such as Nio Inc(NYSE:NIO) have been under pressure recently.\nXpeng bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.\nEach of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nArk Invest bought shares in Xpeng via the ArkAutonomous Technology & Robotics ETF.\nARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.\nTesla Inc is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nTesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.\nHere are a few other key Ark trades from Tuesday:\n\nBought 11,671 shares — estimated to be worth $3 million — in Coinbase Global Inc. The stock closed 1.79% higher at $255.86 a share on Tuesday.\nSold 56,925 shares — estimated to be worth $4.4 million — inJD.com Inc. The stock closed 0.51% lower at $77.65 a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604208881,"gmtCreate":1639397221097,"gmtModify":1639397221387,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604208881","repostId":"2191144607","repostType":4,"isVote":1,"tweetType":1,"viewCount":1036,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604208165,"gmtCreate":1639397207286,"gmtModify":1639397207540,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604208165","repostId":"2191144607","repostType":4,"isVote":1,"tweetType":1,"viewCount":1264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602557670,"gmtCreate":1639046570900,"gmtModify":1639046571083,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602557670","repostId":"1128116582","repostType":4,"isVote":1,"tweetType":1,"viewCount":1424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606140542,"gmtCreate":1638846449780,"gmtModify":1638846449968,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606140542","repostId":"1159148044","repostType":4,"isVote":1,"tweetType":1,"viewCount":1196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601192015,"gmtCreate":1638496134744,"gmtModify":1638496134846,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601192015","repostId":"1119529609","repostType":4,"isVote":1,"tweetType":1,"viewCount":1218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603275417,"gmtCreate":1638419977381,"gmtModify":1638419977684,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603275417","repostId":"1182613816","repostType":4,"repost":{"id":"1182613816","kind":"news","pubTimestamp":1638415076,"share":"https://www.laohu8.com/m/news/1182613816?lang=&edition=full","pubTime":"2021-12-02 11:17","market":"us","language":"en","title":"2 Ridiculously Cheap Dividend Stocks To Buy for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1182613816","media":"Motley Fool","summary":"The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could ","content":"<p>The&nbsp;<b>S&amp;P 500</b>had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.</p>\n<p>For investors looking to get away from this volatility and find more safety, holding dividend stocks in your portfolio can be an excellent decision. They can ensure that you're collecting a recurring stream of income you can use to help offset losses in your portfolio. And at best, they can boost your returns. Two dividend stocks that pay an above-average yield and are incredibly cheap right now are&nbsp;<b>AbbVie</b>(NYSE:ABBV)and&nbsp;<b>ViacomCBS</b>(NASDAQ:VIAC).</p>\n<p>1. AbbVie</p>\n<p>AbbVie makes for an ideal buy-and-forget investment. The&nbsp;healthcare stock&nbsp;yields an impressive 4.8% right now -- well above the&nbsp;<b>S&amp;P 500</b>average of just 1.4%. And the dividend is well supported; in the past 12 months, the company has generated free cash flow of $21.7 billion, more than double the $9 billion in dividends it paid out during that time.</p>\n<p>When the company released its latest quarterly earnings results on Oct. 29, it reported sales of $14.3 billion, 11% higher than the year-ago period. The company also raised its guidance for a third time in 2021, anticipating that its adjusted diluted earnings per share will come in between $12.63 and $12.67 for the full year. That's well above the $5.64 in dividends that the company is paying out annually per share. TheDividend Aristocratalso raised its dividend by 8.5% in a hike that will come into effect next year.</p>\n<p>While investors may be worried about the company's expiring patent on rhe&nbsp;umatoid arthritis drug Humira, AbbVie's management anticipates that newer drugs like Skyrizi and Rinvoq will generate long-term growth and make up for the inevitable decline in Humira's sales. Both drugs still have a long way to go. In just the latest quarter, they achieved combined sales of $1.2 billion in sales while Humira brought in more than $5.4 billion.</p>\n<p>CEO Richard Gonzalez said, \"What we're basically trying to accomplish with the company is build a set of assets that could ultimately significantly replace Humira in the marketplace and be superior to Humira.\"</p>\n<p>Even if there's a dip in profitability, AbbVie has plenty of room to support its dividend. And with other pharma stocks like&nbsp;<b>Pfizer</b>,<b>Merck</b>, and&nbsp;<b>Amgen</b>&nbsp;trading at forward&nbsp;price-to-earnings(P/E) multiples of more than 12, AbbVie's multiple of nine makes the stock look like a bargain buy.</p>\n<p>2. ViacomCBS</p>\n<p>Media and entertainment company ViacomCBS pays a dividend that currently yields right around 3% per year. While it's not as high as AbbVie's payout, the stock could more than make up for that with some possibly stronger gains. Viacom currently trades at a forward P/E of less than nine, which is dirt cheap as streaming stocks&nbsp;<b>WaltDisney</b>&nbsp;and&nbsp;<b>Netflix</b>&nbsp;trade at multiples of 35 and 62, respectively.</p>\n<p>One of the reasons investors aren't as bullish on ViacomCBS is that it still isn't a big rival to those streaming giants. At 47 million global streaming subscribers across its services (including Paramount+), ViacomCBS is nowhere near Netflix's tally of 214 million and has a long way to go in catching up to Disney at over 118 million.</p>\n<p>Plus, ViacomCBS's streaming service isn't even the biggest part of its business. In the latest quarter, its advertising, affiliate, and licensing segments together contributed the vast majority of the company's revenue -- about $5.5 billion in all. However, this latest quarter marked the first time that its global streaming revenue surpassed $1 billion. And with revenue growth of 72% over the year-ago period, streaming is by far the company's fastest-growing segment.</p>\n<p>Although it may not be as popular as its bigger-name rivals, ViacomCBS is posting some strong results of late and it could be an&nbsp;attractive contrarian betto take. Plus, its dividend makes it an even better buy.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Ridiculously Cheap Dividend Stocks To Buy for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Ridiculously Cheap Dividend Stocks To Buy for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 11:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.\nFor investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182613816","content_text":"The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.\nFor investors looking to get away from this volatility and find more safety, holding dividend stocks in your portfolio can be an excellent decision. They can ensure that you're collecting a recurring stream of income you can use to help offset losses in your portfolio. And at best, they can boost your returns. Two dividend stocks that pay an above-average yield and are incredibly cheap right now are AbbVie(NYSE:ABBV)and ViacomCBS(NASDAQ:VIAC).\n1. AbbVie\nAbbVie makes for an ideal buy-and-forget investment. The healthcare stock yields an impressive 4.8% right now -- well above the S&P 500average of just 1.4%. And the dividend is well supported; in the past 12 months, the company has generated free cash flow of $21.7 billion, more than double the $9 billion in dividends it paid out during that time.\nWhen the company released its latest quarterly earnings results on Oct. 29, it reported sales of $14.3 billion, 11% higher than the year-ago period. The company also raised its guidance for a third time in 2021, anticipating that its adjusted diluted earnings per share will come in between $12.63 and $12.67 for the full year. That's well above the $5.64 in dividends that the company is paying out annually per share. TheDividend Aristocratalso raised its dividend by 8.5% in a hike that will come into effect next year.\nWhile investors may be worried about the company's expiring patent on rhe umatoid arthritis drug Humira, AbbVie's management anticipates that newer drugs like Skyrizi and Rinvoq will generate long-term growth and make up for the inevitable decline in Humira's sales. Both drugs still have a long way to go. In just the latest quarter, they achieved combined sales of $1.2 billion in sales while Humira brought in more than $5.4 billion.\nCEO Richard Gonzalez said, \"What we're basically trying to accomplish with the company is build a set of assets that could ultimately significantly replace Humira in the marketplace and be superior to Humira.\"\nEven if there's a dip in profitability, AbbVie has plenty of room to support its dividend. And with other pharma stocks like Pfizer,Merck, and Amgen trading at forward price-to-earnings(P/E) multiples of more than 12, AbbVie's multiple of nine makes the stock look like a bargain buy.\n2. ViacomCBS\nMedia and entertainment company ViacomCBS pays a dividend that currently yields right around 3% per year. While it's not as high as AbbVie's payout, the stock could more than make up for that with some possibly stronger gains. Viacom currently trades at a forward P/E of less than nine, which is dirt cheap as streaming stocks WaltDisney and Netflix trade at multiples of 35 and 62, respectively.\nOne of the reasons investors aren't as bullish on ViacomCBS is that it still isn't a big rival to those streaming giants. At 47 million global streaming subscribers across its services (including Paramount+), ViacomCBS is nowhere near Netflix's tally of 214 million and has a long way to go in catching up to Disney at over 118 million.\nPlus, ViacomCBS's streaming service isn't even the biggest part of its business. In the latest quarter, its advertising, affiliate, and licensing segments together contributed the vast majority of the company's revenue -- about $5.5 billion in all. However, this latest quarter marked the first time that its global streaming revenue surpassed $1 billion. And with revenue growth of 72% over the year-ago period, streaming is by far the company's fastest-growing segment.\nAlthough it may not be as popular as its bigger-name rivals, ViacomCBS is posting some strong results of late and it could be an attractive contrarian betto take. Plus, its dividend makes it an even better buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603094057,"gmtCreate":1638335746598,"gmtModify":1638335760303,"author":{"id":"3564105303063302","authorId":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3564105303063302","authorIdStr":"3564105303063302"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603094057","repostId":"1101502249","repostType":4,"repost":{"id":"1101502249","kind":"news","pubTimestamp":1638330314,"share":"https://www.laohunote.com/m/news/1101502249?lang=&edition=full","pubTime":"2021-12-01 11:45","market":"us","language":"en","title":"Regeneron's COVID-19 antibody drug may be less effective against Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1101502249","media":"Reuters","summary":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag","content":"<p>Nov 30 (Reuters) - <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.</p>\n<p>Global markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.</p>\n<p>Based on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.</p>\n<p>The company said&nbsp;it was doing further study to quantify the potential impact using the variant's genetic sequence.</p>\n<p>One of the antibodies&nbsp;used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.</p>\n<p>\"<a href=\"https://laohu8.com/S/JE\">Just</a> like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"</p>\n<p><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.</p>\n<p>Regeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.</p>\n<p>Rival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.</p>\n<p>The company is \"working to confirm this in the lab as a matter of urgency\", it added.</p>\n<p>Gilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron</p>\n<p>The U.S. Food &amp; Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron's COVID-19 antibody drug may be less effective against Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron's COVID-19 antibody drug may be less effective against Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 11:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after ...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司","LLY":"礼来","MRNA":"Moderna, Inc.","GILD":"吉利德科学"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101502249","content_text":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.\nGlobal markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.\nBased on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.\nThe company said it was doing further study to quantify the potential impact using the variant's genetic sequence.\nOne of the antibodies used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.\n\"Just like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"\nEli Lilly and Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.\nRegeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.\nRival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.\nThe company is \"working to confirm this in the lab as a matter of urgency\", it added.\nGilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron\nThe U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}